SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008; 371: 220112.
  • 2
    Lundberg IE, Alexanderson H. Technology insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathies. Nat Clin Pract Rheumatol 2007; 3: 28290.
  • 3
    Jain M, Smith M, Cintas H, Koziol D, Wesley R, Harris-Love M, et al. Intra-rater and inter-rater reliability of the 10-point Manual Muscle Test (MMT) of strength in children with juvenile idiopathic inflammatory myopathies (JIIM). Phys Occup Ther Pediatr 2006; 26: 517.
  • 4
    Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362: 97182.
  • 5
    Harris-Love MO, Shrader JA, Koziol D, Pahlajani N, Jain M, Smith M, et al. Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology (Oxford) 2009; 48: 1349.
  • 6
    Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2001; 40: 126273.
  • 7
    Oddis CV, Rider LG, Reed AM, Ruperto N, Brunner HI, Koneru B, et al, for the International Myositis Assessment and Clinical Studies Group. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum 2005; 52: 260715.
  • 8
    Kendall FP, McCreary EK, Provance PG. Muscles: testing and function. 4th ed. Baltimore: Williams and Wilkins; 1993.
  • 9
    Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D, Pilkington C, et al. Defining clinical improvement in adult and juvenile myositis. J Rheumatol 2003; 30: 60317.
  • 10
    Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003; 42: 14529.
  • 11
    Cuthbert SC, Goodheart GJ Jr. On the reliability and validity of manual muscle testing: a literature review. Chiropr Osteopat 2007; 15: 4.
  • 12
    Paternostro-Sluga T, Grim-Stieger M, Posch M, Schuhfried O, Vacariu G, Mittermaier C, et al. Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med 2008; 40: 66571.
  • 13
    Bohan A, Peter JB. Polymyositis and dermatomyositis. Part 1. N Engl J Med 1975; 292: 3447.
  • 14
    Bohan A, Peter JB. Polymyositis and dermatomyositis. Part 2. N Engl J Med 1975; 292: 4037.
  • 15
    Rider LG, Feldman BM, Perez MD, Rennebohm RM, Lindsley CB, Zemel LS, et al, in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. I. Physician, parent, and patient global assessments. Arthritis Rheum 1997; 40: 197683.
  • 16
    Adams EM, Pucino F, Yarboro C, Hicks JE, Thornton B, McGarvey C, et al. A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures. J Rheumatol 1999; 26: 35260.
  • 17
    Cabalar I, Villalba ML, Sherman J, Yarboro C, Cintas H, Koziol D, et al. A pilot study of the effect of methimazole, a drug that down-regulates MHC class I, on dermatomyositis and polymyositis [abstract]. Arthritis Rheum 2001; 44 Suppl: S353.
  • 18
    Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, et al, in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. Arthritis Rheum 1999; 42: 22139.
  • 19
    Rider LG. Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002; 28: 93577.
  • 20
    Summers RM, Brune AM, Choyke PL, Chow CK, Patronas NJ, Miller FW, et al. Juvenile idiopathic inflammatory myopathy: exercise-induced changes in muscle at short inversion time inversion-recovery MR imaging. Radiology 1998; 209: 1916.
  • 21
    Nunnally JC. Psychometric theory. 2nd ed. New York: McGraw-Hill; 1978.
  • 22
    Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 3rd ed. Oxford: Oxford University Press; 2003.
  • 23
    Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985; 28: 5427.
  • 24
    Liang MH. Evaluating measurement responsiveness. J Rheumatol 1995; 22: 11912.
  • 25
    Oddis CV, Rider LG, Reed AM, Ruperto N, Brunner HI, Koneru B, et al. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum 2005; 52: 260715.
  • 26
    Huber AM, Rennebohm RM, Maillard SM. Assessing muscle strength, endurance and function. In: RiderLG, PachmanLM, MillerFW, BollarH, editors. Myositis and you: a guide to juvenile dermatomyositis for patients, families and healthcare providers. Washington, DC: The Myositis Association; 2007. p. 13952.
  • 27
    Jain MS, Smith MR, Hicks JE. Rehabilitation of the child with myositis. In: RiderLG, PachmanLM, MillerFW, BollarH, editors. Myositis and you: a guide to juvenile dermatomyositis for patients, families and healthcare providers. Washington, DC: The Myositis Association; 2007. p. 17390.
  • 28
    Hicks JE. The role of rehabilitation in the management of myopathies. Curr Opin Rheumatol 1998; 10: 54855.